Human immunodeficiency virus/human parvovirus B19 co-infection in blood donors and AIDS patients in Sichuan, China

Blood Transfusion

Volumn 10, Issue 4, 2012, Pages 502-514

  He, Miao ^a   Zhu, Jiang ^b   Yin, Huimin ^d   Ke, Ling ^a   Gao, Lei ^a   Pan, Zhihong ^a   Yang, Xiuhua ^a   Li, Wuping ^a,c  

^a INSTITUTE OF BLOOD TRANSFUSION   (China)

^b CHENGDU UNIVERSITY   (China)

^c INSTITUTE OF PATHOGEN BIOLOGY   (China)

^d ACADIA UNIVERSITY   (Canada)

Author keywords

AIDS patients; Co infection; Donors; Human immunodeficiency virus; Human parvovirus B19

Indexed keywords

GENOMIC DNA; IMMUNOGLOBULIN G;

ADOLESCENT; ADULT; AGED; AIDS PATIENT; ARTICLE; BLOOD DONOR; CHINA; FEMALE; GENOMIC FRAGMENT; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN PARVOVIRUS B19; IMMUNOGLOBULIN PRODUCTION; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MONOPHYLY; NUCLEOTIDE SEQUENCE; PARVOVIRUS INFECTION; PHYLOGENY; POLYMERASE CHAIN REACTION; PREVALENCE; SEROPREVALENCE; VIRUS GENOME; VIRUS ISOLATION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGED; ANTIBODIES, VIRAL; BLOOD DONORS; CHINA; DNA, VIRAL; FEMALE; GENOME, VIRAL; HIV-1; HUMANS; MALE; MIDDLE AGED; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; PHYLOGENY; RETROSPECTIVE STUDIES;

EID: 84870040914     PISSN: 17232007     EISSN: None     Source Type: Journal    
DOI: 10.2450/2012.0134-11     Document Type: Article

References (44)

1. Corcoran A, Doyle S. Advances in the biology, diagnosis and host-pathogen interactions of parvovirus B19. J Med Microbiol 2004; 53: 459-75. (Pubitemid 38803039)
2. Shade RO, Blundell MC, Cotmore SF, et al. Nucleotide sequence and genome organization of human parvovirus B19 isolated from the serum of a child during aplastic crisis. J Virol 1986; 58: 921-36. (Pubitemid 16082782)
3. Zhi N, Mills IP, Lu J, et al. Molecular and functional analyses of a human parvovirus B19 infectious clone demonstrates essential roles for NS1, VP1, and the 11-kilodalton protein in virus replication and infectivity. J Virol 2006; 80: 5941-50. (Pubitemid 43849171)
4. Servant A, Laperche S, Lallemand F, et al. Genetic diversity within human erythroviruses: identification of three genotypes. J Virol 2002; 76: 9124-34. (Pubitemid 34919871)
5. Toan NL, Duechting A, Kremsner PG, et al. Phylogenetic analysis of human parvovirus B19, indicating two subgroups of genotype 1 in Vietnamese patients. J Gen Virol 2006; 87: 2941-9. (Pubitemid 44463903)
6. Norja P, Eis-Hubinger AM, Soderlund-Venermo M, et al. Rapid sequence change and geographical spread of human parvovirus B19: comparison of B19 virus evolution in acute and persistent infections. J Virol 2008; 82: 6427-33. (Pubitemid 351875120)
7. Nguyen QT, Wong S, Heegaard ED, Brown KE. Identification and characterization of a second novel human erythrovirus variant, A6. Virology 2002; 301: 374-80. (Pubitemid 35176561)
8. Hokynar K, Soderlund-Venermo M, Pesonen M, et al. A new parvovirus genotype persistent in human skin. Virology 2002; 302: 224-8.
9. Nguyen QT, Sifer C, Schneider V, et al. Detection of an erythrovirus sequence distinct from B19 in a child with acute anaemia. Lancet 1998; 352: 1524. (Pubitemid 28512936)
10. Parsyan A, Addo-Yobo E, Owusu-Ofori S, et al. Effects of transfusion on human erythrovirus B19-susceptible or -infected pediatric recipients in a genotype 3-endemic area. Transfusion 2006; 46: 1593-600. (Pubitemid 44326337)
11. Rinckel LA, Buno BR, Gierman TM, Lee DC. Discovery and analysis of a novel parvovirus B19 genotype 3 isolate in the United States. Transfusion 2009; 49: 1488-92.
12. Sanabani S, Neto WK, Pereira J, Sabino EC. Sequence variability of human erythroviruses present in bone marrow of Brazilian patients with various parvovirus B19-related hematological symptoms. J Clin Microbiol 2006; 44: 604-6. (Pubitemid 43222260)
13. Young NS, Brown KE. Parvovirus B19. N Engl J Med 2004; 350: 586-97.
14. Heegaard ED, Brown KE. Human parvovirus B19. Clin Microbiol Rev 2002; 15: 485-505. (Pubitemid 34761354)
15. Buyukkose M, Kozanoglu E, Basaran S, et al. Seroprevalence of parvovirus B19 in fibromyalgia syndrome. Clin Rheumatol 2009; 28: 305-9.
16. Parsyan A, Candotti D. Human erythrovirus B19 and blood transfusion - an update. Transfus Med 2007; 17: 263-78. (Pubitemid 47197759)
17. Bizjak G, Blondin D, Hammer R, et al. Acute infection with parvovirus B19 in early pregnancy. Ultrasound Obstet Gynecol 2009; 34: 234-5.
18. Bremner JA, Cohen BJ. Parvovirus B19 as a cause of anemia in human immunodeficiency virus-infected patients. J Infect Dis 1994; 169: 938-40. (Pubitemid 24102142)
19. Kurtzman GJ, Cohen BJ, Field AM, et al. Immune response to B19 parvovirus and an antibody defect in persistent viral infection. J Clin Invest 1989; 84: 1114-23. (Pubitemid 19247580)
20. Frickhofen N, Young NS. Persistent parvovirus B19 infections in humans. Microb Pathog 1989; 7: 319-27. (Pubitemid 20087914)
21. Chernak E, Dubin G, Henry D, et al. Infection due to parvovirus B19 in patients infected with human immunodeficiency virus. Clin Infect Dis 1995; 20: 170-3.
22. Frickhofen N, Abkowitz JL, Safford M, et al. Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): a treatable cause of anemia in AIDS. Ann Intern Med 1990; 113: 926-33.
23. Koppelman MH, Rood IG, Fryer JF, et al. Parvovirus B19 genotypes 1 and 2 detection with real-time polymerase chain reaction assays. Vox Sang 2007; 93: 208-15. (Pubitemid 47373990)
24. Ke L, He M, Li C, et al. The prevalence of human parvovirus B19 DNA and antibodies in blood donors from four Chinese blood centers. Transfusion 2011; 51: 1909-18.
25. Corcoran C, Hardie D, Yeats J, Smuts H. Genetic variants of human parvovirus B19 in South Africa: cocirculation of three genotypes and identification of a novel subtype of genotype 1. J Clin Microbiol 2010; 48: 137-42.
26. Cassinotti P, Siegl G. Quantitative evidence for persistence of human parvovirus B19 DNA in an immunocompetent individual. Eur J Clin Microbiol Infect Dis 2000; 19: 886-7.
27. Thompson JD, Gibson TJ, Plewniak F, et al. The CLUSTAL-X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 1997; 25: 4876-82. (Pubitemid 28022245)
28. Nylander JAA. MrModeltest v2. Program distributed by the author: Evolutionary Biology Centre, Uppsala University; 2004.
29. Ronquist F, Huelsenbeck JP. MrBayes 3: Bayesian phylogenetic inference under mixed models. Bioinformatics 2003; 19: 1572-4. (Pubitemid 37038874)
30. Stamatakis A, Hoover P, Rougemont J. A rapid bootstrap algorithm for the RAxML Web servers. Syst Biol 2008; 57: 758-71.
31. Tamura K, Dudley J, Nei M, Kumar S. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 2007; 24: 1596-9. (Pubitemid 47236692)
32. Erdman DD, Durigon EL, Wang QY, Anderson LJ. Genetic diversity of human parvovirus B19: sequence analysis of the VP1/VP2 gene from multiple isolates. J Gen Virol 1996; 77: 2767-74. (Pubitemid 26390577)
33. Thomas I, Di Giambattista M, Gerard C, et al. Prevalence of human erythrovirus B19 DNA in healthy Belgian blood donors and correlation with specific antibodies against structural and non-structural viral proteins. Vox Sang 2003; 84: 300-7. (Pubitemid 36702336)
34. Kooistra K, Mesman HJ, de Waal M, et al. Epidemiology of high-level parvovirus B19 viraemia among Dutch blood donors, 2003-2009. Vox Sang 2011; 100: 261-6.
35. van Elsacker-Neile AM, Kroon FP, van der Ende ME, et al. Prevalence of parvovirus B19 infection in patients infected with human immunodeficiency virus. Clin Infect Dis 1996; 23: 1255-60. (Pubitemid 26423162)
36. Bremner JA, Beard S, Cohen BJ, et al. Secondary infection with parvovirus B19 in an HIV-positive patient. AIDS 1993; 7: 1131-2. (Pubitemid 23246464)
37. Naides SJ, Howard EJ, Swack NS, et al. Parvovirus B19 infection in human immunodeficiency virus type 1-infected persons failing or intolerant to zidovudine therapy. J Infect Dis 1993; 168: 101-5. (Pubitemid 23178735)
38. Zuckerman MA, Williams I, Bremner J, et al. Persistent anaemia in HIV-infected individuals due to parvovirus B19 infection. AIDS 1994; 8: 1191-2. (Pubitemid 24228726)
39. Azevedo KM, Setubal S, Camacho LA, et al. Seroepidemiological study of human parvovirus B19 among human immunodeficiency virus-infected patients in a medium-sized city in Rio de Janeiro, Brazil. Mem Inst Oswaldo Cruz 2009; 104: 901-4.
40. Candotti D, Etiz N, Parsyan A, Allain JP. Identification and characterization of persistent human erythrovirus infection in blood donor samples. J Virol 2004; 78 (22): 12169-78. (Pubitemid 39458736)
41. Norja P, Hokynar K, Aaltonen LM, et al. Bioportfolio: lifelong persistence of variant and prototypic erythrovirus DNA genomes in human tissue. Proc Natl Acad Sci USA 2006; 103: 7450-3. (Pubitemid 43727853)
42. Woolf AD, Cohen BJ. Parvovirus B19 and chronic arthritis - causal or casual association? Ann Rheum Dis 1995; 54: 535-6.
43. Parsyan A, Szmaragd C, Allain JP, Candotti D. Identification and genetic diversity of two human parvovirus B19 genotype 3 subtypes. J Gen Virol 2007; 88 (Pt 2): 428-31. (Pubitemid 46210880)
44. Shackelton LA, Holmes EC. Phylogenetic evidence for the rapid evolution of human B19 erythrovirus. J Virol 2006; 80: 3666-9.